BAP1 and neoplasm: The presence of BAP1 aberration in our cohort was associated with numerically longer OS since MPM diagnosis of 98.3 months (95% CI, 9.7–98.3), as compared to 19.4 months (95% CI, 9.7–47.3) in non-selected MPM and 18.8 months (95% CI, 8.5-NR) in wild-type BAP1 MPM—despite the lack of striking inter-group differences in other baseline patient and tumor characteristics.